Skip to main content
Caplight Logo









Respinor AS

Respinor AS

Private
OsloHealthcare & Life Scienceshttps://respinor.com/

Last Round

Convertible Debt

Jul 21, 2022

Total Funding Raised

$6.99M

Company Overview

Respinor AS is a medical technology company that develops non-invasive, ultrasound-based devices for continuous diaphragm monitoring in critically ill patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

diaphragm monitoringultrasound medical devicemechanical ventilationintensive careICU monitoringpoint of care ultrasoundPOCUSrespiratory monitoringnon-invasive monitoringweaning from ventilationclinical decision supportmedical imagingmedtechsignal processinghealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Respinor AS Comparables

Compare Respinor AS with similar companies based on industry and business-model similarity.

Respinor AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stimdia Medical
74%
Liberate Medical
72%
Lungpacer Medical
70%

Respinor AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJul 21, 2022
Private PlacementJan 4, 2022
GrantDec 11, 2020
GrantApr 20, 2018
GrantDec 1, 2016
Seed
Sep 1, 2016

Key People

Founding team and executive leadership

Trude Tingvoll

Chief Executive Officer

Executive Team

Respinor AS Investors

Notable investors and investment history

Respinor AS investors
InvestorRounds
Inven2Seed
The Research Council of NorwayGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 4, 2026

    Monthly visitors increased 111% MoM, reaching 1.7K.

  • Mar 27, 2025

    Monthly visitors increased 78% MoM.

Respinor AS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Respinor AS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Respinor AS's valuation, stock price, and market status.

Firmographic Details

HeadquartersOslo
Employee Range13
Year Founded2015
Last FundingJul 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?